No association of MDM2 SNP309 with risk of glioblastoma and prognosis
- PMID: 17568997
- DOI: 10.1007/s11060-007-9416-1
No association of MDM2 SNP309 with risk of glioblastoma and prognosis
Abstract
The MDM2 SNP309 variant has been shown to increase MDM2 expression and to be associated with tumor formation. In glioblastomas, the P53/MDM2 pathway is of crucial importance and MDM2 amplification is related to poor prognosis. However, we show here that MDM2 SNP309 is not associated with glioblastoma risk, and is not a prognostic factor.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous